Triangle of Wound Assessment Made Easy: Revisited
DOI:
https://doi.org/10.17140/DRMTOJ-1-114Abstract
Objective: We have provided evidence based critical review of the “Triangle of wound assessment
made easy”.
Background: Wound assessment is a vital step in managing patients with acute and chronic
wounds in daily clinical practice. The natural progression of most wounds is to heal naturally
in a coherent and timely manner, although a minority of wounds will fail to heal. The aim of
treating recalcitrant wounds that fail to heal is to control symptoms and delay or prevent complications.
One vital step in managing wounds is proper and comprehensive evidence based
wound assessment.
Methods: We have carried out literature review including systemic reviews, met analysis pertaining
wound assessment including international guidelines.
Results: We have found few gaps in the proposed “Triangle of wound assessment made easy”
which have been addressed accordingly. We have revised the concept of (infection) i.e. “raised
white blood cell (WBC) count as a sign of infection” and argued that in up to one-half of patients,
even with severe diabetic foot infection raised temperature, WBC count, or sedimentation
rate are absent. A second point of concern is the omission of “probing to bone sign” in the
diagnostic criteria of local signs of infection. Recent clinical studies have demonstrated that in
the presence of a clinically infected ulcer, a positive Probe-to-Bone Test (PTB) test is highly
suggestive of osteomyelitis, but a negative test does not rule out the diagnosis; conversely, in
the situation of an apparently uninfected foot wound, a positive PTB test is not specific for
osteomyelitis, but this diagnosis is unlikely if the PTB test is negative. Lastly, the authors have
suggested reducing wound bio burden/manage infection through the use of topical antimicrobial
therapy-including antiseptic agents. Topical antiseptics have inconclusive proof of efficacy
in various etiology wounds and concern remain regarding their residual cytotoxicity when in
contact with newly forming granulating tissues especially when highly concentrated rinse solutions
is the common practice in developing countries of the world.
References
Dowsett C, Gronemann M, Harding K. Taking wound assess-ment beyond the wound edge. Wounds International. 2015; 6(1): 6-10.
Atiyeh BS, Ioannovich J, Al-Amm CA, El-Musa KA. Man-agement of acute and chronic open wounds: The importance of moist environment in optimal wound healing. Curr Pharm Bio-technol. 2002; 3(3): 179-195.
Schultz GS, Sibbald RG, Falanga V, et al. Wound bed prepara-tion: A systematic approach to wound management. Wound Re-pair Regen. 2003; 11(Suppl 1): S1.
Broughton G 2nd, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006; 117: 12S.
Golinko MS, Clark S, Rennert R, et al. Wound emergencies: The importance of assessment, documentation, and early treat-ment using a wound electronic medical record. Ostomy Wound Manage. 2009; 55: 54-61. Web site. http://s3.amazonaws.com/ academia.edu.documents/42003584/Wound_emergencies_the_ importance_of_asse20160203-6042-131xx49.pdf?AWSAcces sKeyId=AKIAJ56TQJRTWSMTNPEA&Expires=147652265- 2&Signature=GFFV4ChLqvqq1ddfwYxt48dl2w4%3D&respo nse-content-disposition=inline%3B%20filename%3DWound_ emergencies_the_importance_of_asse.pdf. Accessed August 21, 2016.
Brem H, Balledux J, Bloom T, et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing. Arch Surg. 2000; 135: 627.
Brem H, Jacobs T, Vileikyte L, et al. Wound-healing protocols for diabetic foot and pressure ulcers. Surg Technol Int. 2003; 11: 85.
Eneroth M, Apelqvist J, Stenstrom A. Clinical character-istics and outcome in 223 diabetic patients with deep foot in-fections. Foot Ankle Int. 1997; 18: 716-722. doi: 10.1177/ 107110079701801107
Edelson GW, Armstrong DG, Lavery LA, Caicco G. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting. J Am Podiatr Med Assoc. 1997; 87(6): 260- 265.
Armstrong DG, Perales TA, Murff RT, Edelson GW, Welchon JG. Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc. 1996; 86(5): 224-227. doi: 10.7547/87507315-86-5-224
Lipsky BA, Sheehan P, Armstrong DG, Tice AD, Polis AB, Abramson MA. Clinical predictors of treatment failure for dia-betic foot infections: Data from a prospective trial. Int Wound J. 2007; 4: 30-38. doi: 10.1111/j.1742-481X.2006.00274.x
Jeandrot A, Richard JL, Combescure C, et al. Serum pro-calcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: A pilot study. Diabetologia. 2008; 51: 347-352. doi: 10.1007/s00125- 007-0840-8
Uzun G, Solmazgul E, Curuksulu H, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med. 2007; 213: 305-312. doi: 10.1620/tjem.213.305
Newman LG, Waller J, Palestro CJ, et al. Unsuspected os-teomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA. 1991; 266: 1246-1251.
Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg. 1998; 37: 460-466. doi: 10.1016/S1067-2516(98)80022-7
Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: A clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995; 273: 721-723.
Lavery LA, Armstrong DG, Peters EJG, Lipsky BA. Probe-to-bone test for diagnosing diabetic foot osteomyelitis. Diabetes Care. 2007; 30(2): 270-274. doi: 10.2337/dc06-1572
Morales Lozano R, González Fernández ML, Martinez Hernández D, Beneit Montesinos JV, Guisado Jiménez S, Gon-zalez Jurado MA. Validating the probe-to-bone test and other tests for diagnosing chronic osteomyelitis in the diabetic foot. Diabetes Care. 2010; 33(10): 2140-2145. doi: 10.2337/dc09- 2309
White RJ, Cutting K, Kingsley A. Topical antimicrobi-als in the control of wound bioburden. Ostomy Wound Man-age. 2006; 52: 26-58. Web site. http://europepmc.org/abstract/ med/16896238. Accessed August 21, 2016.
Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: Development of an evidence-based global consensus. Diabetes Metab Res Rev. 2016; 32(Suppl 1): 2-6. Web site. http://www.iwgdf.org/files/2015/website_devel-opment.pdf. Accessed August 21, 2016.
Gottrup F, Apelqvist J, Bjansholt T, et al. EWMA document: Antimicrobials and non-healing wounds. Evidence, contro-versies and suggestions. J Wound Care. 2013; 22: S1-89. doi: 10.12968/jowc.2013.22.Sup5.S1
Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT. Topical silver for treating infected wounds. Cochrane Da-tabase Syst Rev. 2007; 24: CD005486. doi: 10.1002/14651858. CD005486.pub2
Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Da-tabase Syst Rev. 2010; 17: CD006478. doi: 10.1002/14651858. CD006478.pub2
Roeder B, Van Gils CC, Maling S. Antibiotic beads in the treatment of diabetic pedal osteomyelitis. J Foot Ankle Surg. 2000; 39: 124-130. doi: 10.1016/S1067-2516(00)80037-X
Nelson EA, O’Mear S, Golder S, et al. Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med. 2006; 23: 348-359. doi: 10.1111/j.1464-5491.2006.01785.x
Al-Lenjawi B, Mohamed H, Al-Ali A, Kherallah B. Are all wound products created equally? The re-emergence of natural honey. The Journal of Diabetic Foot Complications. 2015; 7(2): 26-41. Web site. http://jdfc.org/spotlight/are-all-wound-prod-ucts-created-equally-the-re-emergence-of-natural-honey/. Ac-cessed August 21, 2016.
Mohamed H, Abu Salma M, Al lenjawi B, et al. The effi-cacy and safety of natural honey on the healing of foot ulcers: A case series. Wounds. 2015; 27(4): 103-114. Web site. http://euro-pepmc.org/abstract/med/25855854. Accessed August 21, 2016.
Mohamed H, El Lenjawi B, Abu Salma M, Abdi S. Hon-ey based therapy for the management of a recalcitrant diabetic foot ulcer. J Tissue Viability. 2014; 23(1): 29-33. doi: 10.1016/j. jtv.2013.06.001
Mohamed H, Abu Salma M, Al Lenjawi B, et al. Enhancing primary healing post ray amputation in a diabetic patient: Ef-ficacy of natural honey. J Diabetic Foot Complications. 2014; 6(1): 13-18. Web site. http://jdfc.org/spotlight/enhancing-prima-ry-healing-post-ray-amputation-in-a-diabetic-patient-efficacy-of-natural-honey/. Accessed August 21, 2016.
Mohamed H, Abo Salma M, Al Lenjawi B, et al. The effi-cacy of natural honey in the management of second degree burn complicated by acute dermatitis in a diabetic patient. J Diabetes Metab. 2014; 5: 373.
Mohamed H, Abo Salma M, El-Lenjawi B, Hassan I. Using honey in post-excision malignant melanoma ulcers. J Lymphoe-dema. 2012; 7(1): 41-45.
Al-Lenjawi B, Mohamed H, Abu Salma M, Abo Gouda Z. Natural honey in the management of thermal burn of the foot in a type 2 diabetic patient: A case report. Dermatol Open J. 2016; 1(1): 14-18. doi: 10.17140/DRMTOJ- 1-105
Lipsky BA, Hoey C. Topical antimicrobial therapy for treat-ing chronic wounds. Clin Infect Dis. 2009; 49: 1541-1549. doi: 10.1086/644732
Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Da-tabase Syst Rev. 2006; 1: CD005082. doi: 10.1002/14651858. CD005082.pub2
Hinchliffe RJ, Valk GD, Apelqvist J, et al. A systematic re-view of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2008; 24(Suppl 1): S119-S144. doi: 10.1002/dmrr.825
Hilton JR, Williams DT, Beuker B, Miller DR, Harding KG. Wound dressings in diabetic foot disease. Clin Infect Dis. 2004; 39(Suppl 2): S100-S103. doi: 10.1086/383270
Cutting K, White R, Edmonds M. The safety and efficacy of dressings with silver-addressing clinical concerns. Int Wound J. 2007; 4: 177-184. doi: 10.1111/j.1742-481X.2007.00338.x
Chopra I. The increasing use of silver-based products as an-timicrobial agents: A useful development or a cause for concern? J Antimicrob Chemother. 2007; 59: 587-590. doi: 10.1093/jac/ dkm006
Percival SL, Woods E, Nutekpor M, Bowler P, Radford A, Cochrane C. Prevalence of silver resistance in bacteria isolated from diabetic foot ulcers and efficacy of silver-containing wound dressings. Ostomy Wound Manage. 2008; 54: 30-40.
Health Technology Inquiry Service. Silver dressings for the treatment of patients with infected wounds: A review of clinical and cost-effectiveness. Canadian Agency for Drugs and Tech-nologies in Health. 2010. Web site. https://www.cadth.ca/silver-dressings-treatment-patients-infected-wounds-review-clinical-and-cost-effectiveness-0. Accessed August 21, 2016.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Dermatology (DER) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
